title: FDA's rejection of alemtuzumab divides neurologists.
authors.forename: Asher
authors.initials: A
authors.lastname: Mullard
mesh_terms: D000074323:Alemtuzumab; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D001291:Attitude of Health Personnel; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D006801:Humans; D009103:Multiple Sclerosis / Q000188:drug therapy*; D009462:Neurology; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000074323:Alemtuzumab